Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LAM RESEARCH CORPLRCX · Entity 1467 | Chief Executive Officer | May 22, 2018 | May 23, 2018 |
| QUALCOMM INC/DEQCOM · Entity 2852 | Director | October 08, 2018 | October 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LAM RESEARCH CORP
Report date May 22, 2018 · Filed May 23, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,259 |
Last balance in matching sequence
After 2018-05-22 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2018-05-22 · Exercise / conversion · Acquired 25,122 · Balance 154,381 F1: Amount reported includes shares subject to unvested Restricted Stock Units. Row 2 · 2018-05-22 · Sale · Disposed 3,285 · Balance 151,096 F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $202.32 to $203.31, inclusive. F1: Amount reported includes shares subject to unvested Restricted Stock Units. Row 3 · 2018-05-22 · Sale · Disposed 16,700 · Balance 134,396 F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $203.32 to $204.23, inclusive. F1: Amount reported includes shares subject to unvested Restricted Stock Units. Row 4 · 2018-05-22 · Sale · Disposed 5,137 · Balance 129,259 F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $204.33 to $205.19, inclusive. F1: Amount reported includes shares subject to unvested Restricted Stock Units. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.60 · Expires 2022-02-11 | Direct | 0 |
Reported balance
After 2018-05-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-05-22 · Exercise / conversion · Disposed 25,122 · Balance 0 F5: On 2/11/2015, the reporting person was granted stock options with a graded vesting schedule in which one-third of the total grant vested on each on 2/11/16, 2/11/17, and 2/11/18. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount reported includes shares subject to unvested Restricted Stock Units.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $202.32 to $203.31, inclusive.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $203.32 to $204.23, inclusive.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $204.33 to $205.19, inclusive.
F5: On 2/11/2015, the reporting person was granted stock options with a graded vesting schedule in which one-third of the total grant vested on each on 2/11/16, 2/11/17, and 2/11/18.
QUALCOMM INC/DE
Report date October 08, 2018 · Filed October 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 1,566 |
Reported balance
After 2018-10-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-10-08 · Grant · Acquired 1,566 · Balance 1,566 F1: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) April 5, 2021, (2) death, (3) disability, or (4) a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.
F2: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) April 5, 2021, (2) death, (3) disability, or (4) a change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2018 Filed Oct 9, 2018 21:01 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 1,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-18-000081 · edgardoc.xml · derivative · entry 1 Anstice Martin B · CIK 0001293332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,566 Underlying: Common Stock · 1,566 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) April 5, 2021, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) April 5, 2021, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| May 22, 2018 Filed May 23, 2018 18:34 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,122 | $80.60 Strike: $80.60 | $2,024,833.20 |
DisclosureSEC source: 0000707549-18-000092 · wf-form4_152710044319167.xml · derivative · entry 5 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,122 shares Expires 2022-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On 2/11/2015, the reporting person was granted stock options with a graded vesting schedule in which one-third of the total grant vested on each on 2/11/16, 2/11/17, and 2/11/18. Read SEC document |
| May 22, 2018 Filed May 23, 2018 18:34 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,137 | $204.73 | $1,051,698.01 |
DisclosureSEC source: 0000707549-18-000092 · wf-form4_152710044319167.xml · nonDerivative · entry 4 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,259 F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $204.33 to $205.19, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| May 22, 2018 Filed May 23, 2018 18:34 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 16,700 | $203.73 | $3,402,291.00 |
DisclosureSEC source: 0000707549-18-000092 · wf-form4_152710044319167.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,396 F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $203.32 to $204.23, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| May 22, 2018 Filed May 23, 2018 18:34 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 3,285 | $202.96 | $666,723.60 |
DisclosureSEC source: 0000707549-18-000092 · wf-form4_152710044319167.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,096 F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $202.32 to $203.31, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| May 22, 2018 Filed May 23, 2018 18:34 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 25,122 | $80.60 | $2,024,833.20 |
DisclosureSEC source: 0000707549-18-000092 · wf-form4_152710044319167.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 21, 2018 Filed Mar 22, 2018 21:14 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 11,200 | $225.00 | $2,520,000.00 |
DisclosureSEC source: 0000707549-18-000070 · wf-form4_152175327638460.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,136 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 18,948 | $190.07 Strike: $190.07 | $3,601,446.36 |
DisclosureSEC source: 0000707549-18-000054 · wf-form4_152029528513603.xml · derivative · entry 5 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,948 Underlying: Common Stock · 18,948 shares Expires 2025-03-01 F4 · derivative.exercise_date: The stock option becomes exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 23,687 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-18-000054 · wf-form4_152029528513603.xml · derivative · entry 4 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,687 Underlying: Common Stock · 23,687 shares Expires not disclosed F3 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 03/01/2021. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 02/01/2018 through 01/31/2021. F3 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 03/01/2021. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 02/01/2018 through 01/31/2021. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 18,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-18-000054 · wf-form4_152029528513603.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,336 F2 · shares: The Restricted Stock Units will vest in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 4,566 | $190.07 | $867,859.62 |
DisclosureSEC source: 0000707549-18-000054 · wf-form4_152029528513603.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,386 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,379 | $190.07 | $1,022,386.53 |
DisclosureSEC source: 0000707549-18-000054 · wf-form4_152029528513603.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,952 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:54 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionMarket-based Performance Restricted Stock Unit · Derivative | 41,873 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-18-000018 · wf-form4_151856243419039.xml · derivative · entry 4 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,873 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On 2/11/15, the Reporting Person received a target grant of 41,873 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/11/18. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/1/18. The performance payout was approved at 150% of target. F3 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/1/18. F3 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/1/18. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:54 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,536 | $165.87 | $918,256.32 |
DisclosureSEC source: 0000707549-18-000018 · wf-form4_151856243419039.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,331 F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:54 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 30,237 | $165.87 | $5,015,411.19 |
DisclosureSEC source: 0000707549-18-000018 · wf-form4_151856243419039.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,867 F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:54 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 62,809 | $165.87 | $10,418,128.83 |
DisclosureSEC source: 0000707549-18-000018 · wf-form4_151856243419039.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On 2/11/15, the Reporting Person received a target grant of 41,873 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/11/18. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/1/18. The performance payout was approved at 150% of target. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 21:06 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 4,742 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-17-000174 · wf-form4_151198958139539.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,295 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 19:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 21,993 | $51.76 Strike: $51.76 | $1,138,357.68 |
DisclosureSEC source: 0000707549-17-000168 · wf-form4_151137932040174.xml · derivative · entry 6 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,993 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On 2/18/2014, the reporting person was granted stock options with a graded vesting schedule in which one-third of the total grant vested on each of 2/18/2015, 2/18/2016 and 2/18/2017. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 19:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerCommon Stock | 12,759 | $215.52 | $2,749,819.68 |
DisclosureSEC source: 0000707549-17-000168 · wf-form4_151137932040174.xml · nonDerivative · entry 5 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,037 F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $215.16 to $216.09, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 19:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerCommon Stock | 18,954 | $214.75 | $4,070,371.50 |
DisclosureSEC source: 0000707549-17-000168 · wf-form4_151137932040174.xml · nonDerivative · entry 4 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,796 F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $214.15 to $215.14, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 19:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerCommon Stock | 3,900 | $213.62 | $833,118.00 |
DisclosureSEC source: 0000707549-17-000168 · wf-form4_151137932040174.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,750 F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $213.10 to 214.03, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 19:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerCommon Stock | 600 | $212.43 | $127,458.00 |
DisclosureSEC source: 0000707549-17-000168 · wf-form4_151137932040174.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,650 F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $212.05 to $212.96, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 19:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 21,993 | $51.76 | $1,138,357.68 |
DisclosureSEC source: 0000707549-17-000168 · wf-form4_151137932040174.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 20:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,121 | $51.76 Strike: $51.76 | $161,542.96 |
DisclosureSEC source: 0000707549-17-000166 · wf-form4_151129673845000.xml · derivative · entry 6 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,993 Underlying: Common Stock · 3,121 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 20:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 18,834 | $51.76 Strike: $51.76 | $974,847.84 |
DisclosureSEC source: 0000707549-17-000166 · wf-form4_151129673845000.xml · derivative · entry 5 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,834 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 20:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 3,121 | $211.16 | $659,030.36 |
DisclosureSEC source: 0000707549-17-000166 · wf-form4_151129673845000.xml · nonDerivative · entry 4 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,257 F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $211.00 to $211.44, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 20:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 18,834 | $211.16 | $3,976,987.44 |
DisclosureSEC source: 0000707549-17-000166 · wf-form4_151129673845000.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,378 F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $211.00 to $211.44, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 20:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 3,121 | $51.76 | $161,542.96 |
DisclosureSEC source: 0000707549-17-000166 · wf-form4_151129673845000.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 20:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 18,834 | $51.76 | $974,847.84 |
DisclosureSEC source: 0000707549-17-000166 · wf-form4_151129673845000.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:40 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,696 | $122.22 | $696,165.12 |
DisclosureSEC source: 0000707549-17-000046 · wf-form4_148952401670085.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,993 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $122.15 to $122.38, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:40 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 8,000 | $121.85 | $974,800.00 |
DisclosureSEC source: 0000707549-17-000046 · wf-form4_148952401670085.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,689 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $121.15 to $122.14, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:40 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 34,304 | $120.30 | $4,126,771.20 |
DisclosureSEC source: 0000707549-17-000046 · wf-form4_148952401670085.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,689 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.02 to $121.00, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 27,628 | $0.00 Strike: $119.67 | $0.00 |
DisclosureSEC source: 0000707549-17-000037 · wf-form4_148848983800696.xml · derivative · entry 4 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,801 Underlying: Common Stock · 27,628 shares Expires 2024-03-01 F4 · derivative.exercise_date: 33.3% of the stock options will vest on 3/1/18, 3/1/19, and 3/1/20. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 34,539 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-17-000037 · wf-form4_148848983800696.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,665 Underlying: Common Stock · 34,539 shares Expires not disclosed F3 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/01/20. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/01/17 to 1/31/20. F3 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/01/20. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/01/17 to 1/31/20. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 27,631 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-17-000037 · wf-form4_148848983800696.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,993 F2 · shares: 33.3% of the RSUs will vest on 3/1/18, 3/1/19, and 3/1/20. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,661 | $119.67 | $677,451.87 |
DisclosureSEC source: 0000707549-17-000037 · wf-form4_148848983800696.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,362 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 20:01 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 49,144 | $114.90 | $5,646,645.60 |
DisclosureSEC source: 0000707549-17-000030 · wf-form4_148831206903018.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,023 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 11,572 | $117.48 | $1,359,478.56 |
DisclosureSEC source: 0000707549-17-000022 · wf-form4_148781024184593.xml · nonDerivative · entry 5 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,167 F3 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F6 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $116.98 to $117.94, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 3,928 | $116.70 | $458,397.60 |
DisclosureSEC source: 0000707549-17-000022 · wf-form4_148781024184593.xml · nonDerivative · entry 4 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,739 F3 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.98 to $116.97, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 500 | $115.58 | $57,790.00 |
DisclosureSEC source: 0000707549-17-000022 · wf-form4_148781024184593.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,667 F3 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $114.98 to $115.88, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 17, 2017 Filed Feb 23, 2017 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionMarket-based Performance Restricted Stock Unit · Derivative | 62,789 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-17-000022 · wf-form4_148781024184593.xml · derivative · entry 6 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 62,789 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/17. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. The performance payout was approved at 150% of target. F7 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/17. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. F7 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/17. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. Read SEC document |
| February 17, 2017 Filed Feb 23, 2017 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 94,183 | $114.90 | $10,821,626.70 |
DisclosureSEC source: 0000707549-17-000022 · wf-form4_148781024184593.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 62,789 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/17. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. The performance payout was approved at 150% of target. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 17, 2017 Filed Feb 23, 2017 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 8,737 | $114.90 | $1,003,881.30 |
DisclosureSEC source: 0000707549-17-000022 · wf-form4_148781024184593.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,984 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 18:31 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 4,569 | $115.99 | $529,958.31 |
DisclosureSEC source: 0000707549-17-000015 · wf-form4_148709707718424.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,721 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 21:42 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 8,233 | $108.04 | $889,493.32 |
DisclosureSEC source: 0000707549-17-000002 · wf-form4_148434374411403.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,290 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $107.91 to $108.26, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 21:42 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 7,767 | $107.40 | $834,175.80 |
DisclosureSEC source: 0000707549-17-000002 · wf-form4_148434374411403.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,523 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $106.91 to $107.90, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 23:32 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 400 | $101.48 | $40,592.00 |
DisclosureSEC source: 0000707549-16-000115 · wf-form4_148098076481428.xml · nonDerivative · entry 4 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,290 F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 23:32 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 8,752 | $100.76 | $881,851.52 |
DisclosureSEC source: 0000707549-16-000115 · wf-form4_148098076481428.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,690 F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.46 to $101.42, inclusive. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 23:32 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,583 | $100.20 | $559,416.60 |
DisclosureSEC source: 0000707549-16-000115 · wf-form4_148098076481428.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,442 F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $99.41 to $100.39, inclusive. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 23:32 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 1,265 | $100.21 | $126,765.65 |
DisclosureSEC source: 0000707549-16-000115 · wf-form4_148098076481428.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,025 F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.84, inclusive. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.